Advertisement Columbia Laboratories names new board member - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Columbia Laboratories names new board member

Columbia Laboratories, a specialty pharmaceutical company, has appointed Anthony Campbell to its board of directors.

Mr Campbell is a manager and senior analyst for Dorset Management and a member of Knott Partners Management. Mr Campbell holds a BS degree from McGill University.

Mr Campbell is an independent director under the current NASDAQ national market listing standards and brings to seven the number of independent directors on the company’s eight-person board. Mr Campbell is expected to serve on the board’s audit committee and scientific committee.

Bob Mills, president and CEO of Columbia Laboratories, said: “Tony brings valuable experience in advising public companies in the life sciences industry and can contribute significantly to our company.”